|
|
chromosome organization
|
GO:0051276 |
360 |
0.950
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.894
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
26 |
0.798
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.743
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
24 |
0.723
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
266 |
0.721
|
|
|
|
chromosome separation
|
GO:0051304 |
42 |
0.711
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.708
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
128 |
0.678
|
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.678
|
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.662
|
|
|
|
dna recombination
|
GO:0006310 |
32 |
0.655
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.637
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.635
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
206 |
0.634
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
17 |
0.627
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.620
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.615
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
52 |
0.612
|
|
|
|
dna metabolic process
|
GO:0006259 |
227 |
0.609
|
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.594
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
132 |
0.585
|
|
|
|
regulation of mitosis
|
GO:0007088 |
56 |
0.579
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
23 |
0.575
|
|
|
|
regulation of cell death
|
GO:0010941 |
173 |
0.538
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
78 |
0.535
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.503
|
|
|
|
proteolysis
|
GO:0006508 |
192 |
0.500
|
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.499
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.487
|
|
|
|
regulation of cell development
|
GO:0060284 |
215 |
0.471
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.466
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
248 |
0.449
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
270 |
0.422
|
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.408
|
|
|
|
female germ line cyst formation
|
GO:0048135 |
42 |
0.384
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
92 |
0.378
|
|
|
|
spindle organization
|
GO:0007051 |
253 |
0.374
|
|
|
|
cell cycle dna replication
|
GO:0044786 |
23 |
0.370
|
|
|
|
germ line cyst formation
|
GO:0048134 |
44 |
0.370
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.369
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
87 |
0.365
|
|
|
|
germarium derived female germ line cyst formation
|
GO:0030727 |
42 |
0.363
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
158 |
0.363
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.361
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
36 |
0.357
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.351
|
|
|
|
notch signaling pathway
|
GO:0007219 |
120 |
0.350
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.347
|
|
|
|
dna endoreduplication
|
GO:0042023 |
22 |
0.346
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.344
|
|
|
|
male gamete generation
|
GO:0048232 |
201 |
0.341
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.340
|
|
|
|
endomitotic cell cycle
|
GO:0007113 |
7 |
0.338
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
210 |
0.335
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
29 |
0.317
|
|
|
|
meiosis i
|
GO:0007127 |
59 |
0.317
|
|
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.315
|
|
|
|
asymmetric cell division
|
GO:0008356 |
37 |
0.303
|
|
|
|
immune system process
|
GO:0002376 |
347 |
0.299
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.296
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.295
|
|
|
|
lateral inhibition
|
GO:0046331 |
206 |
0.294
|
|
|
|
zymogen activation
|
GO:0031638 |
20 |
0.294
|
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.288
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.287
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.286
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.276
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
237 |
0.275
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
137 |
0.274
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
22 |
0.269
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.266
|
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.255
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.254
|
|
|
|
eye development
|
GO:0001654 |
323 |
0.253
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.250
|
|
|
|
formation of anatomical boundary
|
GO:0048859 |
37 |
0.239
|
|
|
|
protein phosphorylation
|
GO:0006468 |
169 |
0.228
|
|
|
|
regionalization
|
GO:0003002 |
416 |
0.227
|
|
|
|
segmentation
|
GO:0035282 |
207 |
0.225
|
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
32 |
0.215
|
|
|
|
cell division
|
GO:0051301 |
248 |
0.215
|
|
|
|
eggshell chorion gene amplification
|
GO:0007307 |
9 |
0.215
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
100 |
0.213
|
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.211
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.208
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.205
|
|
|
|
nuclear dna replication
|
GO:0033260 |
1 |
0.201
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
297 |
0.200
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.199
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
39 |
0.199
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.195
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.195
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
87 |
0.191
|
|
|
|
embryonic development via the syncytial blastoderm
|
GO:0001700 |
148 |
0.190
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
34 |
0.188
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
147 |
0.186
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
260 |
0.177
|
|
|
|
eye morphogenesis
|
GO:0048592 |
260 |
0.176
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
103 |
0.176
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
27 |
0.174
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
69 |
0.174
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
219 |
0.172
|
|
|
|
gene silencing
|
GO:0016458 |
138 |
0.169
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
206 |
0.167
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
20 |
0.167
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
25 |
0.163
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
62 |
0.161
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.156
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
277 |
0.155
|
|
|
|
immune response
|
GO:0006955 |
246 |
0.153
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
37 |
0.151
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
72 |
0.151
|
|
|
|
regulation of dna repair
|
GO:0006282 |
5 |
0.149
|
|
|
|
death
|
GO:0016265 |
284 |
0.146
|
|
|
|
response to organophosphorus
|
GO:0046683 |
2 |
0.146
|
|
|
|
appendage development
|
GO:0048736 |
401 |
0.146
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
83 |
0.142
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
276 |
0.141
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.141
|
|
|
|
cellular response to radiation
|
GO:0071478 |
52 |
0.135
|
|
|
|
spermatogenesis
|
GO:0007283 |
200 |
0.133
|
|
|
|
dna replication
|
GO:0006260 |
48 |
0.130
|
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.130
|
|
|
|
protein alkylation
|
GO:0008213 |
43 |
0.123
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
78 |
0.120
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
251 |
0.119
|
|
|
|
regulation of mitotic metaphase anaphase transition
|
GO:0030071 |
26 |
0.119
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
294 |
0.116
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
78 |
0.115
|
|
|
|
spindle assembly
|
GO:0051225 |
80 |
0.115
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
7 |
0.114
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.114
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
69 |
0.112
|
|
|
|
regulation of sister chromatid segregation
|
GO:0033045 |
28 |
0.112
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
242 |
0.111
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.109
|
|
|
|
phosphorylation
|
GO:0016310 |
294 |
0.109
|
|
|
|
skin development
|
GO:0043588 |
65 |
0.109
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.107
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.106
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
23 |
0.105
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
39 |
0.104
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
30 |
0.104
|
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
128 |
0.102
|
|
|
|
organelle localization
|
GO:0051640 |
148 |
0.101
|
|
|
|
regulation of cell division
|
GO:0051302 |
72 |
0.099
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.099
|
|
|
|
regulation of mitotic sister chromatid separation
|
GO:0010965 |
28 |
0.098
|
|
|
|
oocyte development
|
GO:0048599 |
124 |
0.098
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
249 |
0.096
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
63 |
0.096
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
59 |
0.096
|
|
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
28 |
0.093
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.092
|
|
|
|
leg disc morphogenesis
|
GO:0007478 |
80 |
0.092
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.090
|
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.090
|
|
|
|
cell death
|
GO:0008219 |
279 |
0.089
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.088
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
179 |
0.088
|
|
|
|
growth
|
GO:0040007 |
359 |
0.085
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.085
|
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.083
|
|
|
|
nucleosome organization
|
GO:0034728 |
59 |
0.081
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.081
|
|
|
|
chromatin silencing
|
GO:0006342 |
76 |
0.080
|
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.080
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
140 |
0.079
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.079
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.078
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
4 |
0.078
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
4 |
0.077
|
|
|
|
neuronal stem cell division
|
GO:0036445 |
35 |
0.076
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
61 |
0.075
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
52 |
0.075
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.074
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
59 |
0.073
|
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.073
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
5 |
0.073
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
200 |
0.073
|
|
|
|
camera type eye development
|
GO:0043010 |
4 |
0.073
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.072
|
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.072
|
|
|
|
regulation of catabolic process
|
GO:0009894 |
170 |
0.072
|
|
|
|
imaginal disc derived leg morphogenesis
|
GO:0007480 |
80 |
0.072
|
|
|
|
cell growth
|
GO:0016049 |
108 |
0.072
|
|
|
|
negative regulation of notch signaling pathway
|
GO:0045746 |
41 |
0.071
|
|
|
|
protein maturation
|
GO:0051604 |
71 |
0.071
|
|
|
|
protein catabolic process
|
GO:0030163 |
101 |
0.070
|
|
|
|
metaphase anaphase transition of cell cycle
|
GO:0044784 |
28 |
0.070
|
|
|
|
forebrain development
|
GO:0030900 |
2 |
0.070
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
72 |
0.068
|
|
|
|
eggshell formation
|
GO:0030703 |
105 |
0.068
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
34 |
0.068
|
|
|
|
dendrite morphogenesis
|
GO:0048813 |
199 |
0.067
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
10 |
0.067
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.066
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
15 |
0.066
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
32 |
0.066
|
|
|
|
regulation of metaphase anaphase transition of cell cycle
|
GO:1902099 |
26 |
0.066
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.065
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
223 |
0.065
|
|
|
|
aging
|
GO:0007568 |
143 |
0.065
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.064
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
83 |
0.064
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
54 |
0.064
|
|
|
|
actin filament organization
|
GO:0007015 |
126 |
0.063
|
|
|
|
response to radiation
|
GO:0009314 |
155 |
0.062
|
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
266 |
0.062
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
79 |
0.062
|
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
258 |
0.061
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
98 |
0.060
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.059
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
77 |
0.058
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
19 |
0.058
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.058
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
53 |
0.057
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
5 |
0.057
|
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.057
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
94 |
0.057
|
|
|
|
wound healing
|
GO:0042060 |
75 |
0.056
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
163 |
0.056
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
75 |
0.055
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
163 |
0.053
|
|
|
|
centrosome duplication
|
GO:0051298 |
121 |
0.053
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.053
|
|
|
|
double strand break repair
|
GO:0006302 |
26 |
0.052
|
|
|
|
establishment of nucleus localization
|
GO:0040023 |
26 |
0.052
|
|
|
|
developmental maturation
|
GO:0021700 |
172 |
0.052
|
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.052
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
62 |
0.051
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.051
|
|
|
|
regulation of epithelial cell differentiation
|
GO:0030856 |
4 |
0.051
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.050
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
143 |
0.050
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.050
|
|
|
|
positive regulation of metaphase anaphase transition of cell cycle
|
GO:1902101 |
10 |
0.049
|
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.048
|
|
|
|
cuticle pattern formation
|
GO:0035017 |
27 |
0.048
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
58 |
0.047
|
|
|
|
tube morphogenesis
|
GO:0035239 |
191 |
0.046
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
7 |
0.046
|
|
|
|
tube development
|
GO:0035295 |
244 |
0.046
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
2 |
0.045
|
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.045
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
97 |
0.045
|
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.045
|
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.045
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
16 |
0.045
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.044
|
|
|
|
regulation of response to stress
|
GO:0080134 |
200 |
0.044
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
49 |
0.044
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
322 |
0.044
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
156 |
0.044
|
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.044
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.044
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
116 |
0.043
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
13 |
0.043
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
143 |
0.043
|
|
|
|
mitotic cell cycle embryonic
|
GO:0045448 |
38 |
0.043
|
|
|
|
meiotic spindle organization
|
GO:0000212 |
36 |
0.042
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
43 |
0.042
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
90 |
0.042
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
206 |
0.041
|
|
|
|
negative regulation of neuroblast proliferation
|
GO:0007406 |
27 |
0.041
|
|
|
|
histone modification
|
GO:0016570 |
106 |
0.041
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
199 |
0.041
|
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
14 |
0.041
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
58 |
0.041
|
|
|
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
28 |
0.040
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.040
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.040
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
90 |
0.040
|
|
|
|
centrosome cycle
|
GO:0007098 |
137 |
0.040
|
|
|
|
chorion containing eggshell formation
|
GO:0007304 |
105 |
0.040
|
|
|
|
ovarian follicle cell development
|
GO:0030707 |
248 |
0.039
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
271 |
0.039
|
|
|
|
positive regulation of mitotic metaphase anaphase transition
|
GO:0045842 |
10 |
0.039
|
|
|
|
cuticle development
|
GO:0042335 |
86 |
0.039
|
|
|
|
histone methylation
|
GO:0016571 |
40 |
0.038
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
31 |
0.038
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
44 |
0.037
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
40 |
0.037
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
28 |
0.036
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
44 |
0.036
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.036
|
|
|
|
epithelial cell development
|
GO:0002064 |
274 |
0.036
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
293 |
0.035
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
28 |
0.035
|
|
|
|
response to organic substance
|
GO:0010033 |
284 |
0.035
|
|
|
|
eggshell chorion assembly
|
GO:0007306 |
66 |
0.035
|
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.035
|
|
|
|
regulation of immune system process
|
GO:0002682 |
176 |
0.035
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
81 |
0.034
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.034
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
41 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
61 |
0.033
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
55 |
0.033
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
92 |
0.033
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.032
|
|
|
|
macromolecule methylation
|
GO:0043414 |
45 |
0.032
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
51 |
0.032
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
65 |
0.032
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
12 |
0.031
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
87 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.031
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
20 |
0.031
|
|
|
|
neurological system process
|
GO:0050877 |
358 |
0.031
|
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.031
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
92 |
0.030
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
119 |
0.030
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.030
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
3 |
0.030
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
201 |
0.030
|
|
|
|
gliogenesis
|
GO:0042063 |
80 |
0.030
|
|
|
|
embryonic organ development
|
GO:0048568 |
50 |
0.029
|
|
|
|
innate immune response
|
GO:0045087 |
144 |
0.029
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.029
|
|
|
|
nucleosome assembly
|
GO:0006334 |
35 |
0.029
|
|
|
|
regulation of immune response
|
GO:0050776 |
118 |
0.029
|
|
|
|
regulation of dna replication
|
GO:0006275 |
13 |
0.029
|
|
|
|
hippo signaling
|
GO:0035329 |
20 |
0.029
|
|
|
|
telencephalon development
|
GO:0021537 |
2 |
0.029
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.028
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
3 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.028
|
|
|
|
cell fate determination
|
GO:0001709 |
91 |
0.028
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
69 |
0.028
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.028
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.028
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
14 |
0.028
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
2 |
0.027
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
58 |
0.027
|
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.027
|
|
|
|
mitotic spindle organization
|
GO:0007052 |
220 |
0.027
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.027
|
|
|
|
protein import into nucleus
|
GO:0006606 |
51 |
0.027
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
108 |
0.027
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
64 |
0.027
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
23 |
0.026
|
|
|
|
regulation of protein phosphorylation
|
GO:0001932 |
64 |
0.026
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
3 |
0.026
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
31 |
0.026
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
95 |
0.026
|
|
|
|
establishment of chromosome localization
|
GO:0051303 |
20 |
0.026
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
74 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.026
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.026
|
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
139 |
0.026
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
47 |
0.026
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
22 |
0.025
|
|
|
|
respiratory system development
|
GO:0060541 |
213 |
0.025
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
16 |
0.025
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.025
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
106 |
0.025
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
53 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
163 |
0.025
|
|
|
|
oocyte differentiation
|
GO:0009994 |
145 |
0.025
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
105 |
0.024
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
143 |
0.024
|
|
|
|
response to virus
|
GO:0009615 |
28 |
0.024
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.024
|
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.024
|
|
|
|
cystoblast division
|
GO:0007282 |
10 |
0.024
|
|
|
|
regulation of axon extension involved in axon guidance
|
GO:0048841 |
4 |
0.023
|
|
|
|
centrosome organization
|
GO:0051297 |
163 |
0.023
|
|
|
|
dna geometric change
|
GO:0032392 |
16 |
0.023
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.023
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.023
|
|
|
|
maintenance of protein location
|
GO:0045185 |
28 |
0.023
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
240 |
0.023
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
98 |
0.023
|
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.023
|
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.023
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
105 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
1 |
0.022
|
|
|
|
cell cell junction organization
|
GO:0045216 |
55 |
0.022
|
|
|
|
positive regulation of cellular protein metabolic process
|
GO:0032270 |
118 |
0.022
|
|
|
|
cytoskeleton dependent cytokinesis
|
GO:0061640 |
81 |
0.022
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
46 |
0.021
|
|
|
|
organ growth
|
GO:0035265 |
56 |
0.021
|
|
|
|
macroautophagy
|
GO:0016236 |
42 |
0.021
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.021
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
13 |
0.021
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.021
|
|
|
|
positive regulation of chromosome segregation
|
GO:0051984 |
10 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.021
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
63 |
0.021
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
127 |
0.021
|
|
|
|
defense response to other organism
|
GO:0098542 |
225 |
0.020
|
|
|
|
post golgi vesicle mediated transport
|
GO:0006892 |
11 |
0.020
|
|
|
|
dna amplification
|
GO:0006277 |
11 |
0.020
|
|
|
|
dna conformation change
|
GO:0071103 |
105 |
0.020
|
|
|
|
instar larval development
|
GO:0002168 |
55 |
0.020
|
|
|
|
leg disc development
|
GO:0035218 |
92 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.020
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
7 |
0.020
|
|
|
|
nucleosome positioning
|
GO:0016584 |
3 |
0.020
|
|
|
|
stem cell proliferation
|
GO:0072089 |
88 |
0.020
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.020
|
|
|
|
chromosome localization
|
GO:0050000 |
20 |
0.020
|
|
|
|
dna duplex unwinding
|
GO:0032508 |
16 |
0.020
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
45 |
0.020
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
78 |
0.020
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
75 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.019
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
277 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
11 |
0.019
|
|
|
|
response to purine containing compound
|
GO:0014074 |
12 |
0.019
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
168 |
0.019
|
|
|
|
adherens junction organization
|
GO:0034332 |
27 |
0.019
|
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.019
|
|
|
|
chromosome condensation
|
GO:0030261 |
41 |
0.019
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.019
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
89 |
0.019
|
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.018
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
29 |
0.018
|
|
|
|
biological adhesion
|
GO:0022610 |
138 |
0.018
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.018
|
|
|
|
regulation of synapse organization
|
GO:0050807 |
110 |
0.018
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
15 |
0.018
|
|
|
|
response to oxidative stress
|
GO:0006979 |
86 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
201 |
0.018
|
|
|
|
regulation of cell size
|
GO:0008361 |
63 |
0.018
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.018
|
|
|
|
developmental cell growth
|
GO:0048588 |
52 |
0.017
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
24 |
0.017
|
|
|
|
protein localization
|
GO:0008104 |
284 |
0.017
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.017
|
|
|
|
gland morphogenesis
|
GO:0022612 |
145 |
0.017
|
|
|
|
meiotic dna double strand break processing
|
GO:0000706 |
3 |
0.017
|
|
|
|
synapse assembly
|
GO:0007416 |
143 |
0.017
|
|
|
|
developmental pigmentation
|
GO:0048066 |
68 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
89 |
0.017
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
41 |
0.017
|
|
|
|
actomyosin contractile ring assembly
|
GO:0000915 |
10 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.017
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
157 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
97 |
0.017
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
27 |
0.016
|
|
|
|
olfactory behavior
|
GO:0042048 |
97 |
0.016
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
170 |
0.016
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
68 |
0.016
|
|
|
|
dendrite development
|
GO:0016358 |
204 |
0.016
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
31 |
0.016
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
6 |
0.016
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
1 |
0.016
|
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.015
|
|
|
|
regulation of gene silencing
|
GO:0060968 |
63 |
0.015
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
64 |
0.015
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
35 |
0.015
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
34 |
0.015
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
34 |
0.015
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.015
|
|
|
|
positive regulation of dna endoreduplication
|
GO:0032877 |
4 |
0.015
|
|
|
|
maintenance of protein location in cell
|
GO:0032507 |
26 |
0.015
|
|
|
|
head involution
|
GO:0008258 |
35 |
0.015
|
|
|
|
dna packaging
|
GO:0006323 |
91 |
0.015
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
94 |
0.015
|
|
|
|
digestive system development
|
GO:0055123 |
149 |
0.015
|
|
|
|
protein processing
|
GO:0016485 |
68 |
0.015
|
|
|
|
cytokinesis
|
GO:0000910 |
90 |
0.015
|
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.015
|
|
|
|
post embryonic appendage morphogenesis
|
GO:0035120 |
385 |
0.015
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
88 |
0.015
|
|
|
|
cell motility
|
GO:0048870 |
251 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.015
|
|
|
|
nuclear transport
|
GO:0051169 |
72 |
0.015
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.015
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
74 |
0.015
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
2 |
0.014
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
80 |
0.014
|
|
|
|
atp metabolic process
|
GO:0046034 |
49 |
0.014
|
|
|
|
regulation of protein modification process
|
GO:0031399 |
112 |
0.014
|
|
|
|
anaphase promoting complex dependent proteasomal ubiquitin dependent protein catabolic process
|
GO:0031145 |
30 |
0.014
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
2 |
0.014
|
|
|
|
axis specification
|
GO:0009798 |
167 |
0.014
|
|
|
|
nuclear migration
|
GO:0007097 |
20 |
0.014
|
|
|
|
gland development
|
GO:0048732 |
191 |
0.014
|
|
|
|
microtubule anchoring
|
GO:0034453 |
11 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
46 |
0.014
|
|
|
|
cytoplasmic sequestering of protein
|
GO:0051220 |
4 |
0.014
|
|
|
|
cell cycle comprising mitosis without cytokinesis
|
GO:0033301 |
25 |
0.014
|
|
|
|
maintenance of location
|
GO:0051235 |
73 |
0.014
|
|
|
|
cellular protein localization
|
GO:0034613 |
160 |
0.014
|
|
|
|
induction of programmed cell death by hormones
|
GO:0035081 |
12 |
0.014
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
47 |
0.013
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
68 |
0.013
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.013
|
|
